Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial.
Vitamin D deficiency was common among patients with chronic hepatitis C (CHC) and had negative influence on treatment outcome. Correction of vitamin D deficiency improved treatment response. Interferon gamma-induced protein 10 (IP-10) and enzyme dipeptidyl peptidase-4 (DPP IV) involved in inflammato...
Main Authors: | Piyawat Komolmit, Kriangsak Charoensuk, Kessarin Thanapirom, Sirinporn Suksawatamnuay, Panarat Thaimai, Chintana Chirathaworn, Yong Poovorawan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5380326?pdf=render |
Similar Items
-
Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study
by: Piyawat Komolmit, et al.
Published: (2017-08-01) -
Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
by: Kessarin Thanapirom, et al.
Published: (2015-01-01) -
Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C
by: Kessarin Thanapirom, et al.
Published: (2019-09-01) -
Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients
by: Kessarin Thanapirom, et al.
Published: (2017-04-01) -
Stability of hepatitis B virus pregenomic RNA in plasma specimens under various temperatures and storage conditions
by: Pakkapon Rattanachaisit, et al.
Published: (2021-04-01)